2005.HK Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 11:08):

Stats
Šios dienos apimtis	2.42M
Vidutinė apimtis	2.05M
Rinkos kapitalizacija	14.16B
EPS	HKD0 ( 2024-03-27 )
Last Dividend	HKD0.0700 ( 2023-09-14 )
Next Dividend	HKD0 ( N/A )
P/E	10.84
ATR14	HKD0.00700 (0.15%)

Tūris Koreliacija

Ilgas: -0.12 (neutral)

Trumpas: -0.43 (neutral)

Signal:(48.323) Neutral

SSY Group Ltd Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

SSY Group Ltd Koreliacija - Valiuta/Žaliavos

0.11
( neutral )

-0.19
( neutral )

0.00
( neutral )

0.67
( moderate )

-0.22
( neutral )

SSY Group Ltd Finansinės ataskaitos

Annual	2023
Pajamos:	HKD6.46B
Bruto pelnas:	HKD3.49B (53.99 %)
EPS:	HKD0.440

FY	2023
Pajamos:	HKD6.46B
Bruto pelnas:	HKD3.49B (53.99 %)
EPS:	HKD0.440

FY	2022
Pajamos:	HKD6.43B
Bruto pelnas:	HKD3.44B (53.46 %)
EPS:	HKD0.380

FY	2021
Pajamos:	HKD5.36B
Bruto pelnas:	HKD3.17B (59.18 %)
EPS:	HKD0.260

Financial Reports:

No articles found.

SSY Group Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.0600 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.160 (N/A)	HKD0.0700 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

SSY Group Ltd Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.77 - Increase likely (55.42%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.00500	2008-05-23
Last Dividend	HKD0.0700	2023-09-14
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	32	--
Total Paid Out	HKD1.257	--
Avg. Dividend % Per Year	0.00%	--
Score	4.32	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.77
Div. Directional Score	10.00	--

Next Divdend (Est)
(2024-07-09)

HKD0.0719 Estimate 12.38 %

Dividend Stability

0.50 Below Average

Dividend Score

4.32

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2588.HK	Ex Dividend Knight	2023-09-25	Semi-Annually	0.00%
1382.HK	Ex Dividend Knight	2023-08-15	Semi-Annually	0.00%
0455.HK	Ex Dividend Junior	2023-06-29	Annually	0.00%
6823.HK	Ex Dividend Knight	2023-08-17	Semi-Annually	0.00%
1931.HK	Ex Dividend Knight	2023-09-04	Semi-Annually	0.00%
0966.HK	Ex Dividend Junior	2023-07-10	Sporadic	0.00%
0088.HK	Ex Dividend Knight	2023-09-01	Semi-Annually	0.00%
3316.HK	Ex Dividend Knight	2023-06-20	Annually	0.00%
1528.HK	Ex Dividend Junior	2023-07-13	Sporadic	0.00%
0579.HK	Ex Dividend Knight	2023-07-05	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.204	1.500	5.92	8.88	[0 - 0.5]
returnOnAssetsTTM	0.110	1.200	6.33	7.59	[0 - 0.3]
returnOnEquityTTM	0.199	1.500	8.91	10.00	[0.1 - 1]
payoutRatioTTM	0.338	-1.000	6.62	-6.62	[0 - 1]
currentRatioTTM	2.03	0.800	4.84	3.87	[1 - 3]
quickRatioTTM	1.587	0.800	5.37	4.30	[0.8 - 2.5]
cashRatioTTM	0.659	1.500	7.45	10.00	[0.2 - 2]
debtRatioTTM	0.282	-1.500	5.31	-7.96	[0 - 0.6]
interestCoverageTTM	11.88	1.000	6.71	6.71	[3 - 30]
operatingCashFlowPerShareTTM	0.325	2.00	9.89	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0880	2.00	9.96	10.00	[0 - 20]
debtEquityRatioTTM	0.486	-1.500	8.06	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.540	1.000	4.34	4.34	[0.2 - 0.8]
operatingProfitMarginTTM	0.231	1.000	7.39	7.39	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.287	1.000	9.52	9.52	[0.2 - 2]
assetTurnoverTTM	0.540	0.800	9.73	7.79	[0.5 - 2]
Total Score				12.25

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	10.78	1.000	9.01	0	[1 - 100]
returnOnEquityTTM	0.199	2.50	9.30	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0880	2.00	9.97	10.00	[0 - 30]
dividendYielPercentageTTM	4.81	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.325	2.00	9.89	10.00	[0 - 30]
payoutRatioTTM	0.338	1.500	6.62	-6.62	[0 - 1]
pegRatioTTM	0.559	1.500	9.61	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.149	1.000	8.76	0	[0.1 - 0.5]
Total Score				7.77

SSY Group Ltd

SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; and food, beverages, and catering business. It sells its products under Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was incorporated in 2004 and is headquartered in Wanchai, Hong Kong. SSY Group Limited is a subsidiary of China Pharmaceutical Co., Ltd.